EVIFX
Price
$12.70
Change
-$0.01 (-0.08%)
Updated
Sep 5 closing price
Net Assets
1.07B
RLBFX
Price
$38.08
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
257.73B
Interact to see
Advertisement

EVIFX vs RLBFX

Header iconEVIFX vs RLBFX Comparison
Open Charts EVIFX vs RLBFXBanner chart's image
Eaton Vance Balanced A
Price$12.70
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets1.07B
American Funds American Balanced R5
Price$38.08
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets257.73B
EVIFX vs RLBFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EVIFX vs. RLBFX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVIFX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 258B vs. EVIFX (1.07B). RLBFX pays higher dividends than EVIFX: RLBFX (2.05) vs EVIFX (1.20). EVIFX was incepted earlier than RLBFX: EVIFX (93 years) vs RLBFX (23 years). EVIFX (0.97) is less costly to investors than RLBFX (0.29). RLBFX is a more actively managed with annual turnover of: 44.00 vs. EVIFX (5.00). RLBFX has a lower initial minimum investment than EVIFX: RLBFX (250) vs EVIFX (1000). RLBFX annual gain was more profitable for investors over the last year : 10.28 vs. EVIFX (7.60). RLBFX return over 5 years is better than : 41.46 vs. EVIFX (28.98).
EVIFXRLBFXEVIFX / RLBFX
Total Expense Ratio0.970.29334%
Annual Report Gross Expense Ratio0.970.29334%
Fund Existence93 years23 years-
Gain YTD8.43911.56273%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B258B0%
Annual Yield % from dividends1.202.0559%
Returns for 1 year7.6010.2874%
Returns for 3 years35.1440.9286%
Returns for 5 years28.9841.4670%
Returns for 10 years69.6278.4089%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EWTX15.570.95
+6.50%
Edgewise Therapeutics
BTAI3.790.22
+6.16%
BioXcel Therapeutics Inc
ATMCU12.65N/A
N/A
AlphaTime Acquisition Corp
RRC34.70-0.24
-0.69%
Range Resources Corp
KOPN2.12-0.02
-0.93%
Kopin Corp